ロード中...
Tailoring combinatorial cancer therapies to target the origins of adaptive resistance
The development of resistance to chemotherapy is a critical yet poorly understood phenomenon driving cancer-related deaths. We recently reported a study that explored the origins of adaptive chemotherapy resistance. During this investigation we unexpectedly discovered that inherent vulnerabilities w...
保存先:
| 出版年: | Mol Cell Oncol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4845182/ https://ncbi.nlm.nih.gov/pubmed/27308546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2015.1030534 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|